Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study
Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup et al. · 2008
Read Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study by Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003363.txt.
Description
Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup and colleagues trial metformin in type 1 diabetes in this 2008 PLOS ONE paper. Despite intensive insulin treatment, many patients with type 1 diabetes have longstanding inadequate glycaemic control. Metformin is an oral hypoglycaemic agent that improves insulin action in patients with type 2 diabetes. The team investigated effect of a one-year treatment in type 1 patients.
Their randomized study tests adjunct metformin treatment in patients with persistent inadequate control. Readers get trial evidence on borrowing a type 2 drug for type 1 care. Even a modest insulin-sparing effect matters over a lifetime of injections.
Catalog record
| CREATOR | Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003363